{"denoms":[{"counts":[{"groupId":"BG000","value":"83"},{"groupId":"BG001","value":"82"},{"groupId":"BG002","value":"165"}],"units":"Participants"}],"groups":[{"description":"Patients wear Sea-Band acupressure wristbands on each wrist beginning approximately 30 minutes prior to the first cisplatin-containing chemotherapy course and continually for 24 hours after the last chemotherapy dose (acute phase), and for a maximum of 7 days or until the next chemotherapy course starts (delayed phase). Patients are allowed to take bands off intermittently (up to 4 times a day, for no more than 15 minutes each time) to relieve pressure or to bathe. Patients also receive standard of care anti-emetic prophylaxis comprising granisetron, ondansetron, or dexamethasone during chemotherapy according to institutional or physician preference.\n\nReal Acupressure Band: Acupressure wristband","id":"BG000","title":"Arm I- Real Acupressure Bands"},{"description":"Patients wear placebo wristbands on each wrist and receive standard of care anti-emetic prophylaxis during chemotherapy as patients in arm I.\n\nPlacebo Acupressure Band: Sham wristband","id":"BG001","title":"Arm II- Placebo Acupressure Bands"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"4.3","value":"12.5"},{"groupId":"BG001","spread":"4.2","value":"12.9"},{"groupId":"BG002","spread":"4.2","value":"12.7"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"Years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"37"},{"groupId":"BG001","value":"32"},{"groupId":"BG002","value":"69"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"46"},{"groupId":"BG001","value":"50"},{"groupId":"BG002","value":"96"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"17"},{"groupId":"BG002","value":"33"}],"title":"Osteosarcoma"},{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"29"},{"groupId":"BG002","value":"49"}],"title":"Hodgkin Lymphoma"},{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"15"}],"title":"Ewing Sarcoma"},{"measurements":[{"groupId":"BG000","value":"38"},{"groupId":"BG001","value":"30"},{"groupId":"BG002","value":"68"}],"title":"Other"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Diagnosis","unitOfMeasure":"Participants"}],"populationDescription":"93 participants were allocated to acupressure bands and 83 received the intervention. 94 participants were allocated to the placebo bands and 82 received the intervention."}